Sunshine Biopharma Inc. (SBFM) Free cash flow 2016–2025
Sunshine Biopharma Inc. (SBFM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.5MFY2025 · since FY2016: -$317,621 → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | +61.2% |
| FY2024 | -$14.2M | -60.1% |
| FY2023 | -$8.9M | -62.7% |
| FY2022 | -$5.4M | -197.5% |
| FY2021 | -$1.8M | -177.8% |
| FY2020 | -$658,490 | -32.6% |
| FY2019 | -$496,658 | +6.6% |
| FY2018 | -$531,656 | +2.8% |
| FY2017 | -$547,238 | -72.3% |
| FY2016 | -$317,621 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFM financial trends
SBFM RevenueSBFM Net incomeSBFM Net marginSBFM Gross profitSBFM Gross marginSBFM Operating incomeSBFM Operating marginSBFM Operating cash flowSBFM Capital expendituresSBFM Return on equitySBFM Stock buybacksSBFM Dividends paidSBFM Total assetsSBFM Total liabilitiesSBFM Shareholders’ equitySBFM overview →